BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 23426336)

  • 1. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.
    Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Morenghi E; Makuuchi M
    Ann Surg; 2013 May; 257(5):929-37. PubMed ID: 23426336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group.
    Bruix J; Fuster J
    Ann Surg; 2015 Jul; 262(1):e30. PubMed ID: 24374519
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Letter: "A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group": When the Study Setting "Ignores" the Patients.
    Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Makuuchi M
    Ann Surg; 2015 Jul; 262(1):e30-1. PubMed ID: 24253157
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System.
    Mazzaferro V; Roayaie S; Poon R; Majno PE
    Ann Surg; 2015 Jul; 262(1):e17-8. PubMed ID: 24368644
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Letter: "Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on 'Surgical Misinterpretation' of the BCLC Staging System": Real Misinterpretation or Lack of Clarity Within the BCLC?
    Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Makuuchi M
    Ann Surg; 2015 Jul; 262(1):e18-9. PubMed ID: 24263335
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center.
    Garancini M; Nespoli S; Romano F; Uggeri F; Degrate L; Okolicsanyi S; Gianotti L
    J Visc Surg; 2018 Sep; 155(4):275-282. PubMed ID: 29606603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment efficacy and prognostic factors for huge HCC based on Barcelona Clinic Liver Cancer staging.
    Zhang ZM; Zhang YM; Gao S; Yuan WP; Zhao YN; Xiang BD; Wu FX; Wu GB; Liu JY
    Asian Pac J Cancer Prev; 2014; 15(20):8823-8. PubMed ID: 25374214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
    Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
    Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
    Yen YH; Cheng YF; Wang JH; Lin CC; Chen CH; Wang CC
    PLoS One; 2021; 16(3):e0249194. PubMed ID: 33765059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
    Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
    World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.
    Furukawa K; Shiba H; Horiuchi T; Shirai Y; Haruki K; Fujiwara Y; Sakamoto T; Gocho T; Yanaga K
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):199-205. PubMed ID: 28160422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
    Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
    Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
    Ni Q; Jia H; Zhang Y; Lu J; Chang H
    Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective.
    Yang T; Lau WY; Zhang H; Huang B; Lu JH; Wu MC
    World J Gastroenterol; 2015 Jul; 21(27):8256-61. PubMed ID: 26217077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.